Effect of BIA 9-1067 on the Pharmacokinetics of Repaglinide

Clinical trial NCT01536366 · COMPLETED

Trial details

NCT number: NCT01536366
Sponsor: Bial - Portela C S.A.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2009-06-01
Primary completion: 2009-07-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.